Morgan Stanley’s Picard Medical PMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.63K Sell
6,376
-5,177
-45% -$7.51K ﹤0.01% 7072
2025
Q4
$20.2K Buy
11,553
+6,493
+128% +$30.6K ﹤0.01% 6691
2025
Q3
$43K Buy
+5,060
New +$35.7K ﹤0.01% 6457

Other funds holding PMI

Morgan Stanley's PMI Position: Q1 2026 in Review

Morgan Stanley reduced its Picard Medical (PMI) stake by 45% in Q1 2026, selling an estimated $7.51K and leaving 6,376 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #7072.

Morgan Stanley first reported a position in PMI in Q3 2025 and has held it in 3 quarters since. The position peaked at $43K in Q3 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

  • Morgan Stanley held 6,376 shares of Picard Medical worth $6.63K as of Q1 2026.
  • Morgan Stanley sold 5,177 Picard Medical shares in Q1 2026, an estimated $7.51K.
  • Picard Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7072 holding.
  • Morgan Stanley first reported a position in Picard Medical in Q3 2025 and has held it in 3 quarters since.
  • Morgan Stanley's Picard Medical position peaked at $43K in Q3 2025.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.